Test ID: BDIAL
Bleeding Diathesis Profile, Limited
Secondary ID 
A test code used for billing and in test definitions created prior to November 2011
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Useful For Suggests clinical disorders or settings where the test may be helpful
Detection of the more common potential causes of abnormal bleeding (eg, factor deficiencies/hemophilia, von Willebrand disease, factor-specific inhibitors) and a simple screen to evaluate for an inhibitor or severe deficiency of factor XIII (rare).
Profile Information A profile is a group of laboratory tests that are ordered and performed together under a single Mayo Test ID. Profile information lists the test performed, inclusive of the test fee, when a profile is ordered and includes reporting names and individual availability.
| Test ID | Reporting Name | Available Separately | Always Performed |
|---|---|---|---|
| PTC | Prothrombin Time (PT), P | Yes, (order PT) | Yes |
| APTTB | Activated Partial Thrombopl Time, P | Yes, (order APT) | Yes |
| TT | Thrombin Time (Bovine), P | Yes | Yes |
| DIRM | D-Dimer, P | Yes, (order DDI) | Yes |
| SFM | Soluble Fibrin Monomer | No | Yes |
| FIBC | Fibrinogen, P | Yes, (order FIB) | Yes |
| F8A | Coag Factor VIII Activity Assay, P | Yes | Yes |
| VWAG | von Willebrand Factor Ag, P | Yes | Yes |
| VWFX | von Willebrand Factor Activity, P | Yes | Yes |
| FXIII | Factor XIII(13),Scrn | No | Yes |
| CCC | Special Coagulation Interpretation | No | Yes |
Reflex Tests Lists test(s) that may or may not be performed, at an additional charge, depending on the result and interpretation of the initial test(s)
| Test ID | Reporting Name | Available Separately | Always Performed |
|---|---|---|---|
| IBETH | Bethesda Units | No | No |
| F8IS | Coag Factor VIII Assay Inhib Scrn,P | No | No |
| RIST | Ristocetin Cofactor, P | No | No |
| FACTV | Coag Factor V Assay, P | Yes | No |
| F_7 | Coag Factor VII Assay, P | Yes | No |
| F_9 | Coag Factor IX Assay, P | Yes | No |
| F_10 | Coag Factor X Assay, P | Yes | No |
| F_11 | Coag Factor XI Assay, P | Yes | No |
| F_12 | Coag Factor XII Assay, P | Yes | No |
| RPTL | Reptilase Time, P | Yes | No |
| APSM | Alpha-2 Plasmin Inhibitor, P | Yes | No |
| F_2 | Coag Factor II Assay, P | Yes | No |
| DRVT | Dilute Russells Viper Venom Time, P | No | No |
| F9_IS | Factor IX Inhib Scrn | No | No |
| 11_IS | Factor XI Inhib Scrn | No | No |
| F2_IS | Factor II Inhib Scrn | No | No |
| F5_IS | Factor V Inhib Scrn | No | No |
| F7_IS | Factor VII Inhib Scrn | No | No |
| 10_IS | Factor X Inhib Scrn | No | No |
| PNP | Platelet Neutralization Procedure | No | No |
| PTMX | PT Mix 1:1 | No | No |
| APTTM | APTT Mix 1:1 | No | No |
| DRVTM | DRVVT Mix | No | No |
| DRVTC | DRVVT Confirmation | No | No |
| STLA | Staclot LA, P | No | No |
| VWFM | von Willebrand Factor Multimer, P | Yes, (order 8844) | No |
Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.
Initial testing includes: prothrombin time (PT), activated partial thromboplastin time, thrombin time (bovine), fibrinogen, D-dimer, soluble fibrin monomer, coagulation factor VIII activity assay, von Willebrand factor antigen, von Willebrand factor activity, factor XIII screen, and special coagulation interpretation.
If PT is > or =14 seconds, PT mix will be performed.
If APTT is >36 seconds, APTT mix and DRVVT will be performed.
If DRVVT ratio is > or =1.2, DRVVT mix will be performed.
If DRVVT mix ratio is > or =1.2, DRVVT confirmation will be performed
If APTT mix is >36 seconds with no evidence of heparin in samples, platelet neutralization procedure will be performed.
If thrombin time is >23 seconds, reptilase time will be performed.
If von Willebrand factor activity assay is <55%, von Willebrand factor ristocetin cofactor activity assay will be performed.
If von Willebrand factor (VWF) antigen is <55%, the VWF activity is <55%, or the VWF activity:VWF antigen ratio is <0.8, VWF multimer analysis will be performed.
If appropriate, coagulation factor assays or Staclot LA will be performed at an additional charge to clarify significant abnormalities in the screening clotting times.
If factor VIII result is <55%, the factor VIII inhibitor screen may be performed along with the Bethesda titering assay, if inhibitor screen is positive.
Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test
Method Name A short description of the method used to perform the test
PTC/6599, PTMX/9053, APTTB/6548, APTTM/9118, TT/9059, FXIII/9068, RPTL/9078, DVRT/80340, DRVTM/32467, DRVTC/32468, STLA/82756: Clot-Based Assay
F_2/9121, FACTV/9054, F_7/9055, F_10/9066, F2_IS/7806, F5_IS/7808, F7_IS/7810, 10_IS/7812: Prothrombin Time Clot-Based Assay
F8A/9070, F_9/9065, F_11/9067, F_12/9069, F9_IS/7802, 11_IS/7804: Activated Partial Thromboplastin Time-Based Clotting Assay
PNP/8866: Activated Partial Thromboplastin Time (APTT) Mixing Test
RIST/9046: Ristocetin Induced Agglutination of Washed Normal Platelets
VWAG/9051, DIRM/6625: Automated Latex Immunoassay (LIA)
SFM/6600: Immunoturbidimetric
FIBC/80343: Clauss Methodology
APSM/9084: Amidolysis of Chromogenic Substrate
VWFM/31046: Agarose Gel Electrophoresis/Infrared Dye-Labeled Antibody Detection
VWFX/89792: Latex Particle Enhanced Immunoassay
IBETH/7288, F8IS/7289: Clot-Based Assay
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
Aliases Lists additional common names for a test, as an aid in searching
Coag
External
link
PDF
document
Excel
document
Word
document